Researchers use CRISPR-edited T cells to treat seriously ill children with resistant leukaemia
Researchers have used CRISPR/Cas9 technology to engineer donor T cells to treat critically ill children with resistant leukemia who had otherwise exhausted all available therapies. The Phase I trial, published in Science Translational Medicine , is the first use of CRISPR-edited “universal” cells in humans and represents a significant advance in the use of genetically […]
